Biosearch Technologies Licenses Genetic Technologies' Non-Coding DNA IP | GenomeWeb
NEW YORK (GenomeWeb News) — Genetic Technologies has licensed certain of its non-coding DNA patents to Biosearch Technologies for research purposes, GTG said today.
 
BTI will use the worldwide license, which includes IP for SNP genotyping and allelic discrimination, to manufacture and distribute oligos, probes, and primers for research use only.
 
All of BTI’s customers will be covered under the GTG patents, GTG said.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.